Kenneth A. Burdick

This profile gathers the share dealings of Kenneth A. Burdick across 3 companies, led by Centene Corp, LifeStance Health Group, Inc. and First Horizon Corp. Over a trading history stretching from 29 April 2021 to 11 August 2026, the count stands at 39 filings.

On the open market, the record shows 1 purchase worth €171k and 4 sales worth €7.3M. The totals exclude 1 filing filed without an amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 34 share grants. In 2026 alone, the filings show no purchases and 2 sales.

On 13 August 2026 came the latest disclosure, an open-market sale for €5.0M in LifeStance Health Group, Inc. The last purchase on record was published on 12 August 2025, which is 432 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.